Angel P. D.
- Country
- Spain
- Department
- Gastroenterology
Research Overview
- Long‑Term Safety and Efficacy of SPY001‑001 Monotherapy and Combination Therapy with Long‑Acting Antibodies in Adults with Ulcerative Colitis
- Evaluation of Guselkumab Subcutaneous Induction Therapy in Patients with Moderately to Severely Active Crohn's Disease: A Randomized, Double-Blind, Placebo-Controlled Study
- A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Data & Insights
Has run more than one trial at 116 of 220 partner sites.
Specializations
Gastroenterology Focus
The investigator specializes in treating inflammatory bowel diseases, with particular emphasis on Crohn's Disease management and therapeutic interventions.
- Moderate to Severe Crohn's Disease
- Inflammatory Bowel Disease Therapy
- Disease Activity Assessment
Their research interests encompass gastrointestinal inflammatory conditions and innovative therapeutic approaches for digestive disorders.
Therapeutic Innovation
The investigator focuses on novel biological therapies and subcutaneous treatment modalities for inflammatory conditions.
- Biological Therapeutics
- Immunological Treatments
- Treatment Response Evaluation
Their work involves evaluating advanced therapeutic options for patients with inflammatory gastrointestinal disorders.
Clinical Outcomes
The investigator's work centers on assessing clinical remission and endoscopic response in gastrointestinal conditions.
- Disease Remission Assessment
- Endoscopic Evaluation
- Treatment Efficacy Monitoring
Their expertise includes monitoring therapeutic outcomes in inflammatory bowel disease treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.